BTG plc (LON:BTG – Get Free Report)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 840 ($11.05) and traded as high as GBX 840 ($11.05). BTG shares last traded at GBX 840 ($11.05), with a volume of 271,742 shares changing hands.
BTG Trading Up 0.1 %
The firm has a 50 day moving average price of GBX 840 and a 200-day moving average price of GBX 840. The firm has a market cap of £3.26 billion and a price-to-earnings ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Articles
- Five stocks we like better than BTG
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- What is the FTSE 100 index?
- Introduction to Fibonacci Retracement Levels
- Canadian Penny Stocks: Can They Make You Rich?
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
